Rational design of k-casein peptides to modulate GSK-3B dynamics for Alzheimer’s therapy
Crossref DOI link: https://doi.org/10.1038/s41598-026-42103-z
Published Online: 2026-03-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moghaddam, Neda
Ramazani, Ali
Zarei, Armin
Text and Data Mining valid from 2026-03-09
Accepted Manuscript valid from 2026-03-09
Article History
Received: 4 November 2025
Accepted: 24 February 2026
First Online: 9 March 2026
Declarations
:
: The authors declare no competing interests.